Director, Translational Medicine

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X. We are seeking a Director of Translational Medicine to join our team. You will provide scientific and strategic leadership for one or more programs supporting the advancement of Crescent ‘s pipeline focusing on next generation immuno-oncology (I/O) and antibody-drug conjugate (ADC). Working with cross-functional teams, you will develop and execute the Translational Medicine strategy to help shape the clinical development plans and contribute to clinical and scientific deliverables.